Skip to main content
Caplight Logo









KinoPharma, Inc.

KinoPharma, Inc.

Private
TokyoHealthcare & Life Scienceshttps://kinopharma.com/

Last Round

Corporate Funding

Apr 25, 2025

Total Funding Raised

$320,000

Company Overview

KinoPharma, Inc. is a clinical-stage biopharmaceutical company that researches and develops small-molecule drugs for viral infections and neurodegenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

kinase inhibitorsdrug discoverysmall-molecule drugsbiotechoncology therapeuticsviral infectionspreclinical developmentdrug licensingin silico analysisbiopharmatargeted therapypharma partnershipsdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KinoPharma, Inc. Comparables

Compare KinoPharma, Inc. with similar companies based on industry and business-model similarity.

KinoPharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharmasum Therapeutics
74%
Alivexis, Inc.
72%
Senhwa Biosciences, Inc.
70%

KinoPharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 25, 2025
Corporate FundingDec 25, 2024
VC RoundJul 31, 2023
Corporate FundingOct 14, 2022
Series DDec 15, 2021
Corporate Funding
Jan 13, 2021

KinoPharma, Inc. Investors

Notable investors and investment history

KinoPharma, Inc. investors
InvestorRounds
Japan Growth Investment AllianceVC Round
QB CapitalVC Round
NCB Venture CapitalVC Round
阿波銀キャピタル株式会社Corporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 41% MoM, reaching 1.2K.

  • Dec 25, 2024

    $320K raised from 阿波銀キャピタル株式会社.

KinoPharma, Inc. Filings

Explore SEC and related filing metadata, where available.

KinoPharma, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about KinoPharma, Inc.'s valuation, stock price, and market status.

Is KinoPharma, Inc. a public or private company?

KinoPharma, Inc. is a private company.

What is the current stock price of KinoPharma, Inc.?

KinoPharma, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is KinoPharma, Inc. worth (valuation)?

Valuation information for KinoPharma, Inc. is not publicly available.

Can I buy KinoPharma, Inc. stock?

KinoPharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was KinoPharma, Inc.'s last funding round?

KinoPharma, Inc.'s most recent funding round was Corporate Funding on April 25, 2025.

Who are the main investors in KinoPharma, Inc.?

Key investors in KinoPharma, Inc. include Japan Growth Investment Alliance.

Will KinoPharma, Inc. IPO soon?

No public IPO plans have been announced for KinoPharma, Inc..

How can I track KinoPharma, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KinoPharma, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range1
Year Founded2005
Last FundingApr 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?